G. Ross
Impact in
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
- Cancer Research top 5%
- Breast Cancer Treatment Studies
Papers in
- Oncology 29
- Lung Cancer Research Studies 15
- HER2/EGFR in Cancer Research 13
- Cancer Treatment and Pharmacology 5
-
- Cancer therapeutics and mechanisms 12
- Co-authors
- Javier Cortés (7 shared papers)Andreas Schneeweiß (5 shared papers)Virginia McNally (2 shared papers)Alexandru Eniu (2 shared papers)Tamas Hickish (2 shared papers)V. Harvey (2 shared papers)Roberto Hegg (3 shared papers)Christoph Tausch (3 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Annals of Oncology (8 papers)Cancer Research (7 papers)European Journal of Cancer (5 papers)Lung Cancer (3 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
G. Ross
48 papers receiving 1.8k citations
G. Ross's Hit Papers
Peers
Comparison fields: 5 of 77
- Oncology 1.1k
- Cancer Research 443
- Reproductive Medicine 214
- Radiology, Nuclear Medicine and Imaging 405
- Pulmonary and Respiratory Medicine 225
Countries citing papers authored by G. Ross
This map shows the geographic impact of G. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Ross more than expected).
Fields of papers citing papers by G. Ross
This network shows the impact of papers produced by G. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Ross. The network helps show where G. Ross may publish in the future.
Co-authors
The 25 scholars most cited alongside G. Ross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA) Hit paper breakdown → | 2013 | 793 |
| 2 | 2011 | 94 | |
| 3 | 2003 | 86 | |
| 4 | 2002 | 82 | |
| 5 | 1999 | 60 | |
| 6 | 2012 | 55 | |
| 7 | 2013 | 52 | |
| 8 | 1997 | 51 | |
| 9 | 2007 | 49 | |
| 10 | 2010 | 49 | |
| 11 | 2011 | 44 | |
| 12 | 2001 | 41 | |
| 13 | 2004 | 38 | |
| 14 | 1995 | 36 | |
| 15 | 1993 | 34 | |
| 16 | 2009 | 31 | |
| 17 | Phase II study of oral topotecan in advanced non-small cell lung cancer. | 2000 | 28 |
| 18 | 2014 | 24 | |
| 19 | 2001 | 16 | |
| 20 | 1997 | 15 |
About G. Ross
G. Ross is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Reproductive Medicine, having authored 48 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (15 papers), HER2/EGFR in Cancer Research (13 papers), Cancer therapeutics and mechanisms (12 papers), Ovarian cancer diagnosis and treatment (7 papers), Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (5 papers), Neuroendocrine Tumor Research Advances (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (443 citations), Reproductive Medicine (214 citations), Radiology, Nuclear Medicine and Imaging (405 citations) and Pulmonary and Respiratory Medicine (225 citations). G. Ross has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Javier Cortés, Andreas Schneeweiß, Virginia McNally, Alexandru Eniu, Tamas Hickish, V. Harvey, Roberto Hegg, Christoph Tausch, Jayantha Ratnayake and Stephen Chia. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, European Journal of Cancer and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.